Close Menu
Home › PrediLife Partners With Institut Curie on Breast Cancer Risk Test

PrediLife Partners With Institut Curie on Breast Cancer Risk Test

May 06, 2019
|
staff reporter

NEW YORK (GenomeWeb) — PrediLife said today that it has signed on the Institut Curie to perform the genetic analysis portion of its MammoRisk breast cancer risk assay.

MammoRisk — used in conjunction with mammograms — is designed to determine breast cancer risk using a patient's age, breast density, family history, and breast biopsy history, as well as a polygenic score based on the analysis of disease-linked genetic variations from a saliva sample.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sep
16
Featured Webinar

Using Next-Generation Sequencing to Detect Genomic Mutations in Hematologic Malignancies

Sponsored by
ArcherDX

This webinar will discuss a next-generation sequencing approach for detecting genomic mutations in hematologic maglignancies.

Oct
03
Featured Webinar

Streamlined and High-Precision Cancer Analysis Using an Automated NGS Workflow in the Reference Lab Setting

This webinar will provide an overview of how an international reference laboratory has implemented an automated next-generation sequencing workflow with custom panels for analyzing cancer samples.

Oct
24
Featured Webinar

Designing, Decoding & Delivering on Genetic Testing for Inherited Disease at Versiti

This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.

What's Popular?

In Molecular Diagnostics

  1. Local Coverage Determinations Roundup: MDxHealth, Myriad, AltheaDx, Natera, and More

  2. Singapore's Inex, Nova Satra Merge to Offer Dx Tests for Asian Women

  3. Nucleic Acid Extraction System From Systaaq Diagnostic CE Marked

  4. Quantabio Continues Newborn Screening Expansion as Tech Adopted by Wisconsin State Program

    Premium

  5. CareDx AlloSure Kidney, Heart Tests Garner Palmetto Draft LCD

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.